{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:20:52Z","timestamp":1793924452659,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373472"],"award-info":[{"award-number":["82373472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173409"],"award-info":[{"award-number":["82173409"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jdsjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jdermsci.2024.10.003","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T14:34:54Z","timestamp":1729607694000},"page":"80-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A carbamazepine metabolite activates NLRP3 and controls skin homing of CD8+ T-cells in SJS\/TEN"],"prefix":"10.1016","volume":"116","author":[{"given":"Chen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JieYu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiXin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunYing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShengXian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongJiang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdermsci.2024.10.003_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","article-title":"SJS\/TEN 2019: from science to translation","volume":"98","author":"Chang","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2024.10.003_bib2","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.24748.1","article-title":"Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Hasegawa","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.jdermsci.2024.10.003_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-0716-2265-0_3","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in the era of systems medicine","volume":"2486","author":"Chen","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.10.003_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamadermatol.2014.4844","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: ear, nose, and throat description at acute stage and after remission","volume":"151","author":"Bequignon","year":"2015","journal-title":"JAMA Dermatol."},{"issue":"12","key":"10.1016\/j.jdermsci.2024.10.003_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat. Med"},{"issue":"5388","key":"10.1016\/j.jdermsci.2024.10.003_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2024.10.003_bib7","first-page":"245ra95","article-title":"An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions","volume":"16","author":"Saito","year":"2014","journal-title":"Sci. Transl. Med"},{"issue":"19","key":"10.1016\/j.jdermsci.2024.10.003_bib8","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1097\/CM9.0000000000003250","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management","volume":"137","author":"Hasegawa","year":"2024","journal-title":"Chin. Med J. (Engl. )"},{"issue":"4","key":"10.1016\/j.jdermsci.2024.10.003_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jaci.2013.09.019","article-title":"Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions","volume":"133","author":"Ichihara","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"574","key":"10.1016\/j.jdermsci.2024.10.003_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6142","article-title":"Plasma exosomal miR-375-3p regulates mitochondria-dependent keratinocyte apoptosis by targeting XIAP in severe drug-induced skin reactions","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci. Transl. Med"},{"issue":"6","key":"10.1016\/j.jdermsci.2024.10.003_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.jdermsci.2024.10.003_bib12","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jdermsci.2024.10.003_bib13","article-title":"NLRP3 inflammasome: checkpoint connecting innate and adaptive immunity in autoimmune diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.jdermsci.2024.10.003_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006196","article-title":"CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1\u03b2 production.","volume":"13","author":"Novais","year":"2017","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.jdermsci.2024.10.003_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.it.2021.05.001","article-title":"NLRP3 inflammasomes that induce antitumor immunity","volume":"42","author":"Zhivaki","year":"2021","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.jdermsci.2024.10.003_bib16","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1074\/jbc.M116.749473","article-title":"Potent NLRP3 inflammasome activation by the HIV reverse transcriptase inhibitor abacavir","volume":"292","author":"Toksoy","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.jdermsci.2024.10.003_bib17","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1007\/s00204-019-02606-3","article-title":"Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice","volume":"93","author":"Wang","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.jdermsci.2024.10.003_bib18","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.4049\/jimmunol.168.6.3079","article-title":"Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis","volume":"168","author":"Akiba","year":"2002","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2024.10.003_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2133.2006.07398.x","article-title":"Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"155","author":"Caproni","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.10.003_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bjd.18942","article-title":"The interferon-\u03b3-induced protein 10\/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms.","volume":"183","author":"Yang","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.10.003_bib21","first-page":"236","article-title":"Serum IFN-\u03b3-inducible chemokines CXCL9 and CXCL10 are elevated in non-immediate drug hypersensitivity reactions","volume":"34","author":"Wang","year":"2016","journal-title":"Asian Pac. J. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.jdermsci.2024.10.003_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/biom11060847","article-title":"Chemokines in severe cutaneous adverse reactions (SCARs)","volume":"11","author":"Miyagawa","year":"2021","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.jdermsci.2024.10.003_bib23","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/dmd.105.006866","article-title":"Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine","volume":"33","author":"Bu","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.jdermsci.2024.10.003_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/17512433.2018.1486707","article-title":"Carbamazepine adverse drug reactions","volume":"11","author":"Fricke-Galindo","year":"2018","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.10.003_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2500\/aap2007.28.3030","article-title":"New concepts in the management of adverse drug reactions","volume":"28","author":"Bahna","year":"2007","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.jdermsci.2024.10.003_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653710","article-title":"Carbamazepine induces focused T cell responses in resolved Stevens-Johnson syndrome and toxic epidermal necrolysis cases but does not perturb the immunopeptidome for T cell recognition","volume":"12","author":"Mifsud","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.jdermsci.2024.10.003_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5114\/aoms.2016.60090","article-title":"The relationship between pharmacokinetic parameters of carbamazepine and therapeutic response in epileptic patients","volume":"13","author":"Chbili","year":"2017","journal-title":"Arch. Med Sci."},{"issue":"2-3","key":"10.1016\/j.jdermsci.2024.10.003_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.imlet.2003.11.013","article-title":"Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1","volume":"91","author":"Huygen","year":"2004","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.10.003_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09629350210307","article-title":"Evidence for local inflammation in complex regional pain syndrome type 1","volume":"11","author":"Huygen","year":"2002","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.jdermsci.2024.10.003_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis: Review of pathogenesis and management","volume":"66","author":"Downey","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2024.10.003_bib31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/epi.12655","article-title":"Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis in Chinese Han patients with epilepsy","volume":"55","author":"He","year":"2014","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.jdermsci.2024.10.003_bib32","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.chemrestox.7b00063","article-title":"Mass spectrometric characterization of circulating covalent protein adducts derived from epoxide metabolites of carbamazepine in patients","volume":"30","author":"Yip","year":"2017","journal-title":"Chem. Res Toxicol."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.10.003_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2006.03.005","article-title":"Activation of T cells by carbamazepine and carbamazepine metabolites","volume":"118","author":"Wu","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2024.10.003_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 Inflammasome and Inflammatory Bowel Disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.10.003_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.jdermsci.2024.10.003_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7326\/0003-4819-153-1-201007060-00030","article-title":"H. Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations","volume":"153","author":"Guigue","year":"2010","journal-title":"Ann. Intern Med"},{"issue":"12","key":"10.1016\/j.jdermsci.2024.10.003_bib37","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","article-title":"IL-1 trap rilonacept in refractory adult onset Still\u2019s disease","volume":"71","author":"Petryna","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.10.003_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.10.003_bib39","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/jid.2013.534","article-title":"Dermal clusters of mature dendritic cells and T cells are associated with the CCL20\/CCR6 chemokine system in chronic psoriasis","volume":"134","author":"Kim","year":"2014","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.10.003_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8+T cells skin trafficking in vitiligo via CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.10.003_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20122006","article-title":"IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells","volume":"210","author":"Ben-Sasson","year":"2013","journal-title":"J. Exp. Med"},{"issue":"10","key":"10.1016\/j.jdermsci.2024.10.003_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jdermsci.2024.10.003_bib43","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1747.2000.00985.x","article-title":"A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions","volume":"114","author":"Reilly","year":"2000","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.jdermsci.2024.10.003_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-immunol-032414-112116","article-title":"Endoplasmic reticulum stress in immunity","volume":"33","author":"Bettigole","year":"2015","journal-title":"Annu Rev. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.10.003_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pharmrev.122.000568","article-title":"Time to Change: A Systems Pharmacology Approach to Disentangle Mechanisms of Drug-Induced Mitochondrial Toxicity","volume":"75","author":"Hoogstraten","year":"2023","journal-title":"Pharm. Rev."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.10.003_bib46","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/cells12050676","article-title":"HLA-B*57:01\/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NF kappaB and JAK\/STAT Pathways","volume":"12","author":"Haukamp","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jdermsci.2024.10.003_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eplepsyres.2015.09.001","article-title":"Effects of CYP3A4\/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy","volume":"117","author":"Wang","year":"2015","journal-title":"Epilepsy Res"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181124002123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181124002123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T02:47:32Z","timestamp":1744253252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181124002123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0923181124002123"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2024.10.003","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A carbamazepine metabolite activates NLRP3 and controls skin homing of CD8+ T-cells in SJS\/TEN","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2024.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}